Kingsway KFS Portfolio Impact Kingsway posts 007 EPS with no available consensus analyst estimates Edison International EIX Q1 2026 Earnings Meet Consensus Analysts Hold Steady Outlooks Amid Sector Growth Disparities HYLN Hyliion Holdings reports slight Q4 2025 EPS miss shares rise 159 percent on positive investor sentiment What Neurogene NGNE is doing that separates it from the herd Market Focus 20260506 How Pimco PML translates market opportunities into growth 013 20260508 HCKT Hackett delivers narrow Q4 2025 earnings beat shares slip 053 percent on muted investor reaction How Saba Capital BRW cash generation compares to earnings The valuation impact of Vivos Therapeutics VVOS earnings quality VVOS Vivos Therapeutics Q4 Earnings Miss Wider Loss Why Azenta AZTA looks attractive at current levels Bullish Momentum 20260508 What Abits ABTS is doing that changes everything On the Radar 20260508 RXRX Recursion Pharmaceuticals posts narrowerthanexpected Q1 2026 loss shares climb 178 on positive investor sentiment DRDB Roman DBDR highlights upcoming deSPAC merger priorities in its latest quarterly earnings release Cheetah CMCM Relative Performance Cheetah posts 110 net loss per share with no analyst estimates AEI Alset posts deep Q3 loss as revenue plummets 788 percent yearoveryear stock holds steady TPST Tempest Therapeutics climbs 251 percent following narrow Q4 2025 EPS beat that lifts investor sentiment